Kimberly-Clark Corporation

Nasdaq KMB · Irving, TX

Works in Psychiatry · Renal & urogenital · Women's health

Kimberly-Clark Corporation is a clinical trial sponsor based in Irving, TX, listed as Nasdaq KMB. It has no active clinical trials as lead sponsor; its trials since 2021 were in Psychiatry, Renal & urogenital and Women's health. Since 2021 it has completed 3 trials and stopped 0 early.

Trial track record · since 2021

0Active trials0 planned participants
3Completed2 with results posted
0Stopped earlyterminated, withdrawn or suspended

Financials · Nasdaq KMB

Cash and equivalents
R&D expense
Net income (loss)
Cash runway

Pipeline · 0 active trials

No active trials with this company as lead sponsor.

Questions about Kimberly-Clark Corporation

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-23.

Approve Suite is not affiliated with Kimberly-Clark Corporation.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.